PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...
Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing ...
OTTAWA, Ontario & YORK, England--(BUSINESS WIRE)--Genvira Biosciences Inc. (“Genvira”), a Canadian innovator in next-generation viral vectors, Labskin Limited (“Labskin”), a leader in 3D in vitro ...
The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...
Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...
The "Adeno-Associated Viral (AAV) Vector Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapy, Therapeutic Area, Route of Administration, Scale of Operation and ...
Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.
NanoMosaic's technology is designed to support upstream and downstream process development, quality control, and release testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results